154 related articles for article (PubMed ID: 23056576)
1. MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.
Wang B; Wang H; Yang Z
PLoS One; 2012; 7(10):e47053. PubMed ID: 23056576
[TBL] [Abstract][Full Text] [Related]
2. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.
Zhang Q; Zhou X; Wan M; Zeng X; Luo J; Xu Y; Ji L; Zhang JA; Fan P; Zhong J; Wu J
Cell Death Dis; 2021 Mar; 12(3):275. PubMed ID: 33723215
[TBL] [Abstract][Full Text] [Related]
3. Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice.
Liang R; Khanna A; Muthusamy S; Li N; Sarojini H; Kopchick JJ; Masternak MM; Bartke A; Wang E
Aging Cell; 2011 Dec; 10(6):1080-8. PubMed ID: 21967153
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 322 Aggravates Dexamethasone-Induced Muscle Atrophy by Targeting
Geng H; Song Q; Cheng Y; Li H; Yang R; Liu S; Hao L
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046161
[TBL] [Abstract][Full Text] [Related]
5. Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.
Rampioni Vinciguerra GL; Capece M; Reggiani Bonetti L; Nigita G; Calore F; Rentsch S; Magistri P; Ballarin R; Di Benedetto F; Distefano R; Cirombella R; Vecchione A; Belletti B; Baldassarre G; Lovat F; Croce CM
Signal Transduct Target Ther; 2024 Feb; 9(1):31. PubMed ID: 38342897
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the epigenetically activated miR-483-5p/IGF-2 pathway results in rapid loss of meningioma tumor cell viability.
Uhlmann EJ; Mackel CE; Deforzh E; Rabinovsky R; Brastianos PK; Varma H; Vega RA; Krichevsky AM
J Neurooncol; 2023 Mar; 162(1):109-118. PubMed ID: 36809604
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1 receptor crosstalk with integrins, cadherins, and the tumor microenvironment: sticking points in understanding IGF1R function in cancer.
Galifi CA; Wood TL
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37490874
[TBL] [Abstract][Full Text] [Related]
8. Regulation of IGF1R by MicroRNA-15b Contributes to the Anticancer Effects of Calorie Restriction in a Murine C3-TAg Model of Triple-Negative Breast Cancer.
Bustamante-Marin X; Devlin KL; McDonell SB; Dave O; Merlino JL; Grindstaff EJ; Ho AN; Rezeli ET; Coleman MF; Hursting SD
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686596
[TBL] [Abstract][Full Text] [Related]
9. Effect of antibiotic monensin on cell proliferation and IGF1R signaling pathway in human colorectal cancer cells.
Zhou Y; Deng Y; Wang J; Yan Z; Wei Q; Ye J; Zhang J; He TC; Qiao M
Ann Med; 2023 Dec; 55(1):954-964. PubMed ID: 36896461
[TBL] [Abstract][Full Text] [Related]
10. MTCH2 stimulates cellular proliferation and cycles via PI3K/Akt pathway in breast cancer.
Jiang W; Miao Y; Xing X; Liu S; Xing W; Qian F
Heliyon; 2024 Mar; 10(6):e28172. PubMed ID: 38560664
[TBL] [Abstract][Full Text] [Related]
11. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.
Shin GC; Lee HM; Kim N; Seo SU; Kim KP; Kim KH
Exp Mol Med; 2024 Feb; 56(1):192-209. PubMed ID: 38200153
[TBL] [Abstract][Full Text] [Related]
12. IGF1R levels in the brain negatively correlate with longevity in 16 rodent species.
Azpurua J; Yang JN; Van Meter M; Liu Z; Kim J; Lobo Ladd AA; Coppi AA; Gorbunova V; Seluanov A
Aging (Albany NY); 2013 Apr; 5(4):304-14. PubMed ID: 23651613
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9764530. PubMed ID: 37829624
[TBL] [Abstract][Full Text] [Related]
14. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.
Fong MY; Zhou W; Liu L; Alontaga AY; Chandra M; Ashby J; Chow A; O'Connor ST; Li S; Chin AR; Somlo G; Palomares M; Li Z; Tremblay JR; Tsuyada A; Sun G; Reid MA; Wu X; Swiderski P; Ren X; Shi Y; Kong M; Zhong W; Chen Y; Wang SE
Nat Cell Biol; 2015 Feb; 17(2):183-94. PubMed ID: 25621950
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
Yan Y; Zhang F; Fan Q; Li X; Zhou K
Neoplasma; 2014; 61(6):672-9. PubMed ID: 25150312
[TBL] [Abstract][Full Text] [Related]
16. miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3.
Nassirpour R; Mehta PP; Yin MJ
PLoS One; 2013; 8(11):e79655. PubMed ID: 24244539
[TBL] [Abstract][Full Text] [Related]
17. The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer.
Ergün S; Ulasli M; Igci YZ; Igci M; Kırkbes S; Borazan E; Balik A; Yumrutaş Ö; Camci C; Cakmak EA; Arslan A; Oztuzcu S
Mol Biol Rep; 2015 Feb; 42(2):497-505. PubMed ID: 25318895
[TBL] [Abstract][Full Text] [Related]
18. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
Elghoroury EA; Abdelghafar EE; Kamel S; Awadallah E; Shalaby A; El-Saeed GSM; Mahmoud E; Kamel MM; Abobakr A; Yousef RN
PLoS One; 2024; 19(5):e0298536. PubMed ID: 38820252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
